MEDANTA Global Health Q1 FY26 results (Apr–Jun 2025) and concall
Global Health reported a strong Q1 FY26, with robust revenue and EBITDA growth driven by increased patient volumes and improved realizations across both mature and developing hospitals. The company is actively expanding its network with the operationalization of the Ranchi hospital and the upcoming launch of the Noida facility. While new unit costs and scheme patient mix impacted some metrics, management remains focused on clinical excellence and strategic capacity expansion.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
What they filed
| Line item | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 |
|---|---|---|---|---|
| Revenue | 665 | 812 | 803 | 882 |
| EBITDA | 150 | 202 | 195 | 195 |
| Net profit | 104 | 131 | 93 | 152 |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.
